Bvf Inc Eledon Pharmaceuticals, Inc. Transaction History
Bvf Inc
- $2.67 Billion
- Q4 2024
A detailed history of Bvf Inc transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 6,293,282 shares of ELDN stock, worth $27.6 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
6,293,282
Previous 6,293,282
-0.0%
Holding current value
$27.6 Million
Previous $15.7 Million
64.26%
% of portfolio
0.96%
Previous 0.5%
Shares
6 transactions
Others Institutions Holding ELDN
# of Institutions
77Shares Held
37.2MCall Options Held
17KPut Options Held
2.7K-
Ra Capital Management, L.P. Boston, MA3.57MShares$15.7 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$12.7 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.55MShares$11.2 Million2.15% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$10.2 Million0.93% of portfolio
-
Blue Owl Capital Holdings LP New York, NY1.96MShares$8.6 Million3.43% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $60.4M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...